Search

Displaying results 8771 - 8780 of 10000 in total
  1. Drug

    TAK-593

    go.drugbank.com/drugs/DB13093
    Investigational

    TAK-593 has been used in trials studying the treatment of Solid Tumors.

  2. Drug

    Flumatinib

    go.drugbank.com/drugs/DB11904
    Investigational

    Flumatinib has been used in trials studying the treatment of Myelogenous Leukemia, Chronic.

  3. Drug

    OBP-801

    go.drugbank.com/drugs/DB12279
    Investigational

    OBP-801 has been used in trials studying the treatment of Solid Tumor.

  4. Drug

    Verucerfont

    go.drugbank.com/drugs/DB12512
    Investigational

    Verucerfont has been used in trials studying the treatment of Congenital Adrenal Hyperplasia.

  5. Drug

    Tedatioxetine

    go.drugbank.com/drugs/DB12641
    Investigational

    Tedatioxetine has been used in trials studying the treatment of Major Depressive Disorder.

  6. Drug

    Olumacostat glasaretil

    go.drugbank.com/drugs/DB12642
    Investigational

    Olumacostat glasaretil has been used in trials studying the treatment of Acne Vulgaris.

  7. Drug

    Ozagrel

    go.drugbank.com/drugs/DB12017
    Investigational

    Ozagrel has been used in trials studying the treatment of Dry Eye Syndromes.

  8. Drug

    Beclabuvir

    go.drugbank.com/drugs/DB12225
    Investigational

    Beclabuvir has been used in trials studying the treatment of Hepatitis C, Chronic.

  9. Drug

    Nelistotug

    go.drugbank.com/drugs/DB19334
    Investigational

    Cell Carcinoma of the Head and Neck- GALAXIES H&N-202). … Nelistotug is under investigation in clinical trial NCT06062420 (A Platform Study of Novel Immunotherapy Combinations as First-line Treatment in Participants With PD-L1 Positive Recurrent/metastatic Squamous

  10. Drug

    Isoquinoline, 7-(2-(3,6-dihydro-4-(3-(trifluoromethyl)phenyl)-1(2h)-pyridinyl)ethyl)-

    go.drugbank.com/drugs/DB16204
    Investigational

    the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis). … Isoquinoline, 7-(2-(3,6-dihydro-4-(3-(trifluoromethyl)phenyl)-1(2h)-pyridinyl)ethyl)- is under investigation in clinical trial NCT00545454 (Activity and Safety of Oral Administration of SSR150106XB for